BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9780111)

  • 1. Use of latanoprost in the treatment of glaucoma associated with Sturge-Weber syndrome.
    Yang CB; Freedman SF; Myers JS; Buckley EG; Herndon LW; Allingham RR
    Am J Ophthalmol; 1998 Oct; 126(4):600-2. PubMed ID: 9780111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latanoprost in glaucoma associated with Sturge-Weber syndrome: benefits and side-effects.
    Altuna JC; Greenfield DS; Wand M; Liebmann JM; Taglia DP; Kaufman PL; Cioffi GA; Lee DA; Robin AL; Crichton A; Costa VP; Ritch R
    J Glaucoma; 1999 Jun; 8(3):199-203. PubMed ID: 10376261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latanoprost for uncontrolled glaucoma in a compassionate case protocol.
    Patelska B; Greenfield DS; Liebmann JM; Wand M; Kushnick H; Ritch R
    Am J Ophthalmol; 1997 Sep; 124(3):279-86. PubMed ID: 9439353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciliochoroidal effusion induced by topical latanoprost in a patient with sturge-weber syndrome.
    Sakai H; Sakima N; Nakamura Y; Nakamura Y; Hayakawa K; Sawaguchi S
    Jpn J Ophthalmol; 2002; 46(5):553-5. PubMed ID: 12457915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare case of overlapping Sturge-Weber syndrome and Klippel-Trenaunay syndrome associated with bilateral refractory childhood glaucoma.
    Pillai MR; Hasini PP; Ahuja A; Krishnadas SR
    Indian J Ophthalmol; 2017 Jul; 65(7):623-625. PubMed ID: 28724825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The evaluation of the efficacy of treatment in glaucoma associated with Sturge-Weber syndrome].
    Oziebło-Kupczyk M; Urban B; Mrugacz M; Bakunowicz-Lazarczyk A
    Klin Oczna; 2007; 109(1-3):46-8. PubMed ID: 17687912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased iris pigment in a child due to latanoprost.
    Brown SM
    Arch Ophthalmol; 1998 Dec; 116(12):1683-4. PubMed ID: 9869807
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of surgical and medical management of glaucoma in Sturge-Weber syndrome.
    Iwach AG; Hoskins HD; Hetherington J; Shaffer RN
    Ophthalmology; 1990 Jul; 97(7):904-9. PubMed ID: 2381705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlapping of Sturge Weber syndrome and Klippel Trenaunay Weber syndrome.
    Rahman M; Rahman S; Rahman M; Akhter S; Kawser C
    Mymensingh Med J; 2008 Jan; 17(1):78-81. PubMed ID: 18285739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of Goniosurgery for Glaucoma Associated With Sturge-Weber Syndrome.
    Yeung HH; Kane SA; Turlapati N; Nzuna JS; Walton DS
    J Pediatr Ophthalmol Strabismus; 2020 Nov; 57(6):384-387. PubMed ID: 33211896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sturge-Weber-Dimitri syndrome associated with Klippel-Trenaunay syndrome].
    Belli L; Delmar A; Abulafia J; González Rescigno GR; Estrada E; Repetto A; Calvo E
    Med Cutan Ibero Lat Am; 1980; 8(1-3):59-63. PubMed ID: 6267388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trabeculectomy for glaucoma associated with Sturge-Weber syndrome.
    Ali MA; Fahmy IA; Spaeth GL
    Ophthalmic Surg; 1990 May; 21(5):352-5. PubMed ID: 2381658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Infantile-Onset Glaucoma Associated With Port Wine Birthmarks and Other Periocular Cutaneous Vascular Malformation.
    Reyes-Capó D; Cavuoto KM; Chang TC
    Asia Pac J Ophthalmol (Phila); 2018; 7(2):95-98. PubMed ID: 29280366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of trabeculotomy and guarded filtration procedure for glaucoma associated with Sturge-Weber syndrome.
    Irkeç M; Kiratli H; Bilgiç S
    Eur J Ophthalmol; 1999; 9(2):99-102. PubMed ID: 10435421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of goniotomy/trabeculotomy in early-onset glaucoma associated with the Sturge-Weber syndrome.
    Olsen KE; Huang AS; Wright MM
    J AAPOS; 1998 Dec; 2(6):365-8. PubMed ID: 10532726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ahmed glaucoma valve implant for management of glaucoma in Sturge-Weber syndrome.
    Hamush NG; Coleman AL; Wilson MR
    Am J Ophthalmol; 1999 Dec; 128(6):758-60. PubMed ID: 10612515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.
    Aung T; Chew PT; Yip CC; Chan YH; See JL; Khng CG; Hoh ST; Ng LH; Lee HM
    Am J Ophthalmol; 2001 May; 131(5):636-42. PubMed ID: 11336940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
    Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.
    Sponsel WE; Paris G; Trigo Y; Pena M
    Am J Ophthalmol; 2002 Oct; 134(4):552-9. PubMed ID: 12383812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of a 1-day, 1-eye trial on the 1-month ocular hypotensive response of latanoprost 0.005%.
    Mansberger SL; Passo MS; Schalock PI; Cioffi GA
    Am J Ophthalmol; 2001 Dec; 132(6):869-71. PubMed ID: 11730650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.